ea0021p108 | Clinical practice/governance and case reports | SFEBES2009
Bujawansa Sumudu
, Leong King Sun
, Leonard Maureen
, Wolstenholme Helen
, Khalathil Dhanya
, Fraser William
Introduction: Hypoparathyroidism is normally treated with calcium salts and activated vitamin D. Here we report a case where synthetic 134 PTH (teriparatide) and i.m. vitamin D was successful in treating a case of primary hypoparathyroidism resistant to conventional treatment.Case report: A 16-year girl presented to the emergency department with vacant episodes and mild confusion. Her childhood was uneventful until the age of 12 when she developed ...